Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Let's not forget that LFB has plenty to gain by seeing GTCB become a valuable stock in the future.
Bump?
"Or are there other benefits to owning a major stake in a publicly traded U.S. company that play a factor?"
How about when you own a lot of stock, your net worth can rise if that stock rises :)
And if GTCB stock were to perform well, they could raise some nice capital for future GTCB pursuits by way of an offering of even more GTCB stock to the public.
Vin and Cro, hoping for the best. We're certainly back in the game which is better than many were expecting.
Madcity, sell now? I don't think so.
Now there is a possibility this stock might come to be worth some decent amount in the future.
Let's not forget that LFB has plenty to gain by seeing GTCB become a valuable stock in the future.
Yeah but no protection should already be priced in to the stock.
"when you had head cheerleader Dew who spoke,saw,heard no evil with GTCB all of a sudden jump ship after facing reality of GTCB, that tells you something."
It tells me it's time to buy. It's probably as undervalued as it will ever be.
Yeah but those issues are factored in. That's why the price is where it is... Same point I was trying to make a few months ago when it was less than half this after the news of the so called awful financing deal.
It's almost as if money isn't worth anything anymore... Go figure?
john, what about drugs that no longer enjoy patent protection?
john, you wrote: "I thought that GTC overstated the value of being able to produce already approved drugs via Transgenics."
If I may ask you to what degree do you feel GTCB "overstated" the savings of producing drugs via transgenics?
And you wrote "thought". So I'll ask if you still think GTCB is overstating the value of producing drugs via transgenics?
All of the above! My initial reaction was to say "screw management" and vote against... However, the sad reality is there is nothing worse than running out of money. One can already see the affect it has. The situation could get even worse without this deal.
At the same time, there's nothing better in this world than having more time.
At least more time gives us a chance to get some semblence of profits in the end (as diluted as they may be).
I figure the dilution is now built into the share price, which is one of the reasons I have added more shares... But I've never been afraid to gamble large.
I know it's these newly purchased shares which can return the most money to me upon any future increase in the share price (if that takes place)...
The sudden realization I'm going to support the deal is making me want to puke. But we are pinned against the wall.
And buying more time may very well prove to be more valuable than the dilution.
It's not an easy decision. One or more of you fine people give me a good reason to change my mind and I won't hesitate to do so!!!
"Then why isn't anyone come forward with a buyout proposal?"
You know how it is... They see a company in financial distress and think there's no hurry to buy it out and maybe they can get it cheaper...
But then when that first offer comes in to buyout, suddenly we find there is more than one suitor. They understand the future of the goats and suddenly can't bid enough to out do each other and we are up to $10/share!
Okay time to put down the bong.
The bottom line, if there is more than one company interested perhaps we come out smelling okay... At least on shares purchased at these prices... That's exactly why I have been adding every day since the latest gruesome chapter in this heartbreaker.
Luck to all!
At any rate it had to be done. So a chance still exists that shareholders can see appreciation of the stock down the road---- especially on any shares purchased at this low level.
Luck to everyone
Cro - you wrote "That logic will be wrong if they sign a lucrative FOB partnership soon but I can not believe that to be the case when they just did such a horrible financing. In other words they did not need to sign the store over to LFB if they thought that another partnership with upfront cash was about to materialize."
But what if they only needed a little more time to ink a partnership which brings in the cash they need?
Then maybe it wouldn't matter as much that this financing was so awful, as they could pay it off.
"LFB will eventually swallow GTCB for peanuts"... Even if peanuts is .50, .75 or $1.00 that's still 2x to 4x from these prices. Kinda why I bought.
I can't see selling after a 40% drop. So I did the opposite.
If I were him, I'd do the right thing and give an interest-free loan to the company out of my own pocket.
Fingers crossed for tomorrow bigworld.
Luck to the patients. Luck to the holders.
Big news. Oppenheimer discloses 11.7% stake in AVII.
6+ million shares.
http://www.sec.gov/Archives/edgar/data/728889/000072888906000168/avibiopharma13g.htm
Check out recent ebola news per USAMRIID.
Applicable to other ssRNA viruses such as HCV & influenza.
It's happening now.
Looks to be this year's big winner.
Is anybody following Prana?
Even those appear to be under water now in AH.
http://yahoo.smartmoney.com/onedaywonder/index.cfm?story=20060123&afl=yahoo
Various updates for ONCY
NCI sponsored phase II melanoma trial and phase I/II ovarian cancer trial
http://biz.yahoo.com/prnews/060118/to114.html?.v=19
Phase I recurrent malignant glioma trial 6 month follow up (note surviving patients continue to be followed)
http://biz.yahoo.com/prnews/060117/to070.html?.v=21
Phase I advanced malignancies systemic trial (poster presentation and webcast)
http://www.oncolyticsbiotech.com/Modified-Clinical_Poster_debono_1-11.pdf
http://www.integratir.com/presentations.asp?ticker=t.onc
It has begun.
kaiva,
Thank you for your excellent responses.
CED allowing for delivery of up to 30x the virus with a wider distribution certainly makes sense to me.
Ah, this is one I *wish* I could answer, though my best guess is backed up by my investment. If I recall correctly, the HC protocol addresses the low permeability issue by using multiple injections per patient and various techniques to guide those needles to known sites of tumor growth.
My money is also betting on good life extension. I believe Dr. Thompson stated something to the effect of "the longer the wait, generally means the better the results".
Oncolytics management does seem to feel that the FDA's suggestion was a good one from the viewpoint of maximizing efficacy. But of course it sent them back to the lab for another series of lab experiments and animal trials, which are far more time-consuming than most investors seem to think.
People certainly get discouraged easily when progress takes longer than a day. However, if the pump delivers increased efficacy, could it lead to drug approval at an earlier stage of the trial?
Earlier approval could effectively result in a "wash" in terms of overall time, but also provide for a more effective treatment option with greater acceptance, and higher pricing for the treatment. A win for patients and shareholders.
Thank you for the heads up re: the board.
P.S. Long awaited news today was nice.
Any guesses on what it could be about the infusion pump compared to the intratumoural injection that could overcome the low permeability of brain tissue to fluid diffusion you mentioned, such that more reovirus could be deliverd into greater proximity to the max amount of cancerous growth?
Do you have any feel or guess as to how much of a limiting factor low permeability of brain tissue to fluid diffusion has been in the HC trial? After all, at least 3 patients demontrated (and may still be demonstrating) life extension. Although, it's possible the LE might not be related. But probably has something to do with it.
At the very least they seem to have isolated what they are up against in terms of effective delivery into the brain. And perhaps the approval for U.S trial delay ends up working in their favor... Would they have used the infusion pump if this trial had been approved 3 years ago?